Your email has been successfully added to our mailing list.

×
0 0 0 0 0 -0.00609756097560984 -0.00609756097560984 -0.00609756097560984
Stock impact report

TCR2 Therapeutics Deepens Manufacturing and Immuno-Oncology Expertise with Key Hires

TCR2 Therapeutics Inc. (TCRR)  More Company Research Source: GlobeNewswire
Last tcr2 therapeutics inc. earnings: 11/12 07:00 am Check Earnings Report
PDF Expansion of leadership team to support clinical trials with an emphasis on manufacturing, IND enablement and development of next generation of TRuC-T cells CAMBRIDGE, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer, today announced an expansion of its leadership team to strengthen expertise in manufacturing, Investigational New Drug (IND) enablement and innovation as the Company advances its approach of creating next generation TRuCTM-T cells addressing the tumor microenvironment. “It is a pleasure to expand our leadership team with experts that deepen three core TCR2 competencies – manufacturing, IND enablement and innovation,” said Garry Menzel, Ph.D., President and Chief Executive Officer of TCR2 Therapeutics. “Earlier this year we established a manufacturing footprint in the United Kingdom by becoming the first U.S. [Read more]
Impact snapshot Event time: TCRR
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
TCRR alerts

from News Quantified
Opt-in for
TCRR alerts

from News Quantified